He Hao, Cheng Xin, Zhao Mengna, Wan Shimeng, Yao Shijie, Cai Hongbing
Department of Gynaecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Department of Gynecology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, Hubei, China.
Front Surg. 2025 Mar 25;12:1443605. doi: 10.3389/fsurg.2025.1443605. eCollection 2025.
Asian females with ovarian cancer have different clinicopathological characteristics compared with other races. However, an effective prognostic prediction tool is lacking. The goal of our study was to develop and evaluate nomograms for estimating overall survival and cancer-specific survival in Asian patients with ovarian cancer.
We extracted data from 2010 to 2018 in the Surveillance, Epidemiology, and End Results database, focusing on Asian/Pacific Islander females that had been diagnosed with epithelial ovarian cancer. To find prognostic factors, least absolute shrinkage and selection operator Cox regression and multivariate Cox regression analyses were used. Based on the outcomes, nomograms were then constructed. Numerous techniques, such as the C-index, calibration plots, decision curve analysis, and risk subgroup stratification, were used to assess the performance of the nomograms.
Nomograms were created to evaluate overall survival and cancer-specific survival rates over three and five years. The C-indices for overall survival and cancer-specific survival in the training cohort were 0.768 and 0.778, respectively. The C-indices for overall survival and cancer-specific survival in the validation cohort were 0.804 and 0.812, respectively. The calibration plots showed that the nomogram forecasts and actual survival results agreed. Additionally, the decision curve analysis curves indicated that the nomogram outperformed the American Joint Commission on Cancer staging system in terms of predictive accuracy.
Nomograms and a risk classification system were created to forecast the overall survival and cancer-specific survival of Asian females with ovarian cancer. The nomograms and risk stratification system have the potential to provide valuable assistance in making future clinical decisions.
与其他种族相比,亚洲卵巢癌女性具有不同的临床病理特征。然而,目前缺乏有效的预后预测工具。我们研究的目的是开发并评估用于估计亚洲卵巢癌患者总生存期和癌症特异性生存期的列线图。
我们从监测、流行病学和最终结果数据库中提取了2010年至2018年的数据,重点关注被诊断为上皮性卵巢癌的亚洲/太平洋岛民女性。为了找到预后因素,使用了最小绝对收缩和选择算子Cox回归以及多变量Cox回归分析。然后根据结果构建列线图。使用了多种技术,如C指数、校准图、决策曲线分析和风险亚组分层,来评估列线图的性能。
创建了列线图以评估三年和五年的总生存率和癌症特异性生存率。训练队列中总生存期和癌症特异性生存期的C指数分别为0.768和0.778。验证队列中总生存期和癌症特异性生存期的C指数分别为0.804和0.812。校准图显示列线图预测与实际生存结果一致。此外,决策曲线分析曲线表明,列线图在预测准确性方面优于美国癌症联合委员会分期系统。
创建了列线图和风险分类系统来预测亚洲卵巢癌女性的总生存期和癌症特异性生存期。列线图和风险分层系统有可能为未来的临床决策提供有价值的帮助。